5,5',5'',5'''-(Ethene-1,1,2,2-tetrayl)tetrakis(2-hydroxybenzaldehyde), 97%, 1g

6-Phenyl-4,5-dihydro-2H-pyridazin-3-one, 95.0%, 5g

2,2-Bis(3-amino-4-methylphenyl)hexafluoropropane, 98.0%, 25g

1,1,2,2-Tetra(biphenyl-4-yl)ethene, 98%, 250mg

1-(2-Methoxyethyl)-3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 98%, 5g

1-(6-Nitro-1,3-benzodioxol-5-yl)ethanol>98.0%(GC)5g

SRC KINASE INHIBITOR I, 95%, 100mg

3-((tert-Butoxycarbonyl)amino)tetrahydrofuran-3-carboxylic acid, 95.0%, 5g

1-(Cyanomethyl)pyridinium Chloride>98.0%(T)5g

4-Methylquinoline-6-carbonitrile, 97%, 250mg

2-(3-Bromophenyl)-1,1,1-trifluoropropan-2-ol, 95%, 500mg

N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-L-alanine>98.0%(HPLC)(T)5g

(1H-Pyrrolo[2,3-b]pyridin-5-yl)boronic acid, 95.0%, 500mg